{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26147394", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "11"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "07", "Day": "06"}], "ELocationID": ["e0132052", "10.1371/journal.pone.0132052"], "Language": ["eng"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "10", "Issue": "7", "PubDate": {"Year": "2015"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.", "Pagination": {"StartPage": "e0132052", "MedlinePgn": "e0132052"}, "Abstract": {"AbstractText": ["Koelreuteria henryi Dummer, an endemic plant of Taiwan, has been used as a folk medicine for the treatment of hepatitis, enteritis, cough, pharyngitis, allergy, hypertension, hyperlipidemia, and cancer. Austrobailignan-1, a natural lignan derivative isolated from Koelreuteria henryi Dummer, has anti-oxidative and anti-cancer properties. However, the effects of austrobailignan-1 on human cancer cells have not been studied yet. Here, we showed that austrobailignan-1 inhibited cell growth of human non-small cell lung cancer A549 and H1299 cell lines in both dose- and time-dependent manners, the IC50 value (48 h) of austrobailignan-1 were 41 and 22 nM, respectively. Data from flow cytometric analysis indicated that treatment with austrobailignan-1 for 24 h retarded the cell cycle at the G2/M phase. The molecular event of austrobailignan-1-mediated G2/M phase arrest was associated with the increase of p21Waf1/Cip1 and p27Kip1 expression, and decrease of Cdc25C expression. Moreover, treatment with 100 nM austrobailignan-1 for 48 h resulted in a pronounced release of cytochrome c followed by the activation of caspase-2, -3, and -9, and consequently induced apoptosis. These events were accompanied by the increase of PUMA and Bax, and the decrease of Mcl-1 and Bcl-2. Furthermore, our study also showed that austrobailignan-1 was a topoisomerase 1 inhibitor, as evidenced by a relaxation assay and induction of a DNA damage response signaling pathway, including ATM, and Chk1, Chk2, \u03b3H2AX phosphorylated activation. Overall, our results suggest that austrobailignan-1 is a novel DNA damaging agent and displays a topoisomerase I inhibitory activity, causes DNA strand breaks, and consequently induces DNA damage response signaling for cell cycle G2/M arrest and apoptosis in a p53 independent manner."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC; Department of Medical Research, Chung-Shan Medical University Hospital, Taichung, Taiwan, ROC."}], "LastName": "Wu", "ForeName": "Chun-Chi", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry, Providence University, Taichung, Taiwan, ROC."}], "LastName": "Huang", "ForeName": "Keh-Feng", "Initials": "KF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROC; Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC."}], "LastName": "Yang", "ForeName": "Tsung-Ying", "Initials": "TY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, ROC."}], "LastName": "Li", "ForeName": "Ya-Ling", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Taiwan Seed Improvement and Propagation Station, Council of Agriculture, Propagation Technology Section, Taichung, Taiwan, ROC."}], "LastName": "Wen", "ForeName": "Chi-Luan", "Initials": "CL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, ROC."}], "LastName": "Hsu", "ForeName": "Shih-Lan", "Initials": "SL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health and Nutrition, Chia Nan University of Pharmacy & Science, Tainan, Taiwan, ROC."}], "LastName": "Chen", "ForeName": "Tzu-Hsiu", "Initials": "TH"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "0", "NameOfSubstance": "TP53 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Topoisomerase I Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Protein p53"}, {"RegistryNumber": "55955-07-2", "NameOfSubstance": "austrobailignan 1"}, {"RegistryNumber": "EC 5.99.1.2", "NameOfSubstance": "DNA Topoisomerases, Type I"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA Topoisomerases, Type I"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Lignans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "M Phase Cell Cycle Checkpoints"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Topoisomerase I Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Suppressor Protein p53"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jemal A, Siegel R, Xu J, Ward E. Cancer statics. CA Cancer Journal for Clinicians. 2010;60:277\u2013300.", "ArticleIdList": ["20610543"]}, {"Citation": "Department of Health T. Vital Statistics Vital Statistics, DOH. 2005."}, {"Citation": "Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. Jama. 2002;287(9):1132\u201341.", "ArticleIdList": ["PMC4037163", "11879110"]}, {"Citation": "Reck M, Heigener DF, Mok T, Soria J-C, Rabe KF. Management of non-small-cell lung cancer: recent developments. The Lancet. 2013;382(9893):709\u201319.", "ArticleIdList": ["23972814"]}, {"Citation": "Elmore S. Apoptosis: a review of programmed cell death. Toxicologic pathology. 2007;35(4):495\u2013516.", "ArticleIdList": ["PMC2117903", "17562483"]}, {"Citation": "Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cellular and molecular life sciences. 2009;66(8):1326\u201336. 10.1007/s00018-008-8637-6", "ArticleIdList": ["10.1007/s00018-008-8637-6", "19099185"]}, {"Citation": "Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clinical cancer research. 2009;15(4):1126\u201332. 10.1158/1078-0432.CCR-08-0144", "ArticleIdList": ["10.1158/1078-0432.CCR-08-0144", "PMC3182268", "19228717"]}, {"Citation": "Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Molecular cell. 2001;7(3):673\u201382.", "ArticleIdList": ["11463391"]}, {"Citation": "Villunger A, Michalak EM, Coultas L, M\u00fcllauer F, B\u00f6ck G, Ausserlechner MJ, et al. p53-and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science. 2003;302(5647):1036\u20138.", "ArticleIdList": ["14500851"]}, {"Citation": "Letai A. PUMA strikes Bax. The Journal of cell biology. 2009;185(2):189\u201391. 10.1083/jcb.200903134", "ArticleIdList": ["10.1083/jcb.200903134", "PMC2700380", "19380876"]}, {"Citation": "Yang CS, Wang Z-Y. Tea and cancer. Journal of the National Cancer Institute. 1993;85(13):1038\u201349.", "ArticleIdList": ["8515490"]}, {"Citation": "Song Y-N, Zhang H-L, Chang C-j, Bollag DM. Cytotoxic cyclolignans from Koelreuteria henryi. Journal of natural products. 1994;57(12):1670\u20134.", "ArticleIdList": ["7714533"]}, {"Citation": "Chiang Y-Y, Wang S-L, Yang C-L, Yang H-Y, Yang H-C, Sudhakar J, et al. Extracts of Koelreuteria henryi Dummer induce apoptosis and autophagy by inhibiting dihydrodiol dehydrogenase, thus enhancing anticancer effects. International journal of molecular medicine. 2013;32(3):577\u201384. 10.3892/ijmm.2013.1441", "ArticleIdList": ["10.3892/ijmm.2013.1441", "23857115"]}, {"Citation": "R\u00edos JL, Giner RM, Prieto JM. New findings on the bioactivity of lignans. Studies in natural products chemistry. 2002;26:183\u2013292."}, {"Citation": "Kamal A, Suresh P, Ramaiah MJ, Srinivasa Reddy T, Kapavarapu RK, Rao BN, et al. 4 \u03b2-[4\u2032-(1-(Aryl) ureido) benzamide] podophyllotoxins as DNA topoisomerase I and II\u03b1 inhibitors and apoptosis inducing agents. Bioorganic & medicinal chemistry. 2013;21(17):5198\u2013208.", "ArticleIdList": ["23849207"]}, {"Citation": "Mukherjee T, Chowdhury S, Kumar A, Majumder HK, Jaisankar P, Mukhopadhyay S. Saracoside: a new lignan glycoside from Saraca indica, a potential inhibitor of DNA topoisomerase IB. Natural product communications. 2012;7(6):767\u20139.", "ArticleIdList": ["22816303"]}, {"Citation": "Li G, Lee C-S, Woo M-H, Lee S-H, Chang H-W, Son J-K. Lignans from the bark of Machilus thunbergii and their DNA topoisomerases I and II inhibition and cytotoxicity. Biological and Pharmaceutical Bulletin. 2004;27(7):1147\u201350.", "ArticleIdList": ["15256759"]}, {"Citation": "Axelson M, Larsson O. Podophyllotoxin derivatives as igf-1r inhibitors. Google Patents; 2004."}, {"Citation": "Lin CY, Chen PN, Hsu LS, Kuo DY, Chu SC, Hsieh YS. Inhibition of the invasion and migration of renal carcinoma 786\u2011o\u2011si3 cells in vitro and in vivo by Koelreuteria formosana extract. Molecular medicine reports. 2014.", "ArticleIdList": ["25241754"]}, {"Citation": "Cheng S-B, Wu L-C, Hsieh Y-C, Wu C-H, Chan Y-J, Chang L-H, et al. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. Induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells. Journal of agricultural and food chemistry. 2012;60(38):9620\u201330.", "ArticleIdList": ["22946656"]}, {"Citation": "Wu CC, Yu C-TR, Chang G-C, Lai J-M, Hsu S-L. Aurora-A promotes gefitinib resistance via a NF-\u03baB signaling pathway in p53 knockdown lung cancer cells. Biochemical and biophysical research communications. 2011;405(2):168\u201372. 10.1016/j.bbrc.2011.01.001", "ArticleIdList": ["10.1016/j.bbrc.2011.01.001", "21216229"]}, {"Citation": "Lee T-H, Chiang Y-H, Chen C-H, Chen P-Y, Lee C-K. A new flavonol galloylrhamnoside and a new lignan glucoside from the leaves of Koelreuteria henryi Dummer. Journal of natural medicines. 2009;63(2):209\u201314. 10.1007/s11418-009-0314-z", "ArticleIdList": ["10.1007/s11418-009-0314-z", "19184275"]}, {"Citation": "Fonseca SF, R\u00faveda EA, McChesney JD. < sup> 13 C NMR analysis of podophyllotoxin and some of its derivatives. Phytochemistry. 1980;19(7):1527\u201330."}, {"Citation": "Su Y-T, Chang H-L, Shyue S-K, Hsu S-L. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochemical pharmacology. 2005;70(2):229\u201341.", "ArticleIdList": ["15941563"]}, {"Citation": "Chen K-C, Yang T-Y, Wu C-C, Cheng C-C, Hsu S-L, Hung H-W, et al. Pemetrexed Induces S-Phase Arrest and Apoptosis via a Deregulated Activation of Akt Signaling Pathway. PloS one. 2014;9(5):e97888 10.1371/journal.pone.0097888", "ArticleIdList": ["10.1371/journal.pone.0097888", "PMC4029963", "24847863"]}, {"Citation": "Hsieh Y-C, Rao YK, Wu C-C, Huang C-YF, Geethangili M, Hsu S-L, et al. Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin-and Bax-triggered mitochondrial pathway. Chemical research in toxicology. 2010;23(7):1256\u201367. 10.1021/tx100116a", "ArticleIdList": ["10.1021/tx100116a", "20557081"]}, {"Citation": "Collins AR. The comet assay for DNA damage and repair. Molecular biotechnology. 2004;26(3):249\u201361.", "ArticleIdList": ["15004294"]}, {"Citation": "Fukuda M, Nishio K, Kanzawa F, Ogasawara H, Ishida T, Arioka H, et al. Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells. Cancer research. 1996;56(4):789\u201393.", "ArticleIdList": ["8631015"]}, {"Citation": "Beretta G, Gatti L, Benedetti V, Perego P, Zunino F. Small molecules targeting p53 to improve antitumor therapy. Mini reviews in medicinal chemistry. 2008;8(9):856\u201368.", "ArticleIdList": ["18691143"]}, {"Citation": "El-Deiry WS. The role of p53 in chemosensitivity and radiosensitivity. Oncogene. 2003;22(47):7486\u201395.", "ArticleIdList": ["14576853"]}, {"Citation": "Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nature reviews Molecular cell biology. 2008;9(5):402\u201312. 10.1038/nrm2395", "ArticleIdList": ["10.1038/nrm2395", "18431400"]}, {"Citation": "El-Deiry WS, editor Regulation ofp53downstream genes Seminars in cancer biology; 1998: Elsevier."}, {"Citation": "Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nature Reviews Cancer. 2009;9(10):749\u201358. 10.1038/nrc2723", "ArticleIdList": ["10.1038/nrc2723", "PMC2771725", "19776744"]}, {"Citation": "Legarza K, Yang L-X. New molecular mechanisms of action of camptothecin-type drugs. Anticancer research. 2006;26(5A):3301\u20135.", "ArticleIdList": ["17094444"]}, {"Citation": "Beretta GL, Perego P, Zunino F. Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors. 2008.", "ArticleIdList": ["18781823"]}, {"Citation": "Smith J, Mun Tho L, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Advances in cancer research. 2010;108(C):73\u2013112.", "ArticleIdList": ["21034966"]}, {"Citation": "Turner T, Caspari T. When heat casts a spell on the DNA damage checkpoints. Open biology. 2014;4(3):140008.", "ArticleIdList": ["PMC3971410", "24621867"]}, {"Citation": "Boohaker R, Xu B. The versatile functions of ATM kinase. Biomedical journal. 2014;37(1):3 10.4103/2319-4170.125655", "ArticleIdList": ["10.4103/2319-4170.125655", "PMC4136744", "24667671"]}, {"Citation": "Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death & Differentiation. 2006;13(6):951\u201361.", "ArticleIdList": ["16575405"]}, {"Citation": "Agarwal C, Tyagi A, Agarwal R. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Molecular cancer therapeutics. 2006;5(12):3294\u2013302.", "ArticleIdList": ["17172433"]}, {"Citation": "Zhao Y, Wu Z, Zhang Y, Zhu L. HY\u20101 induces G2/M cell cycle arrest in human colon cancer cells through the ATR\u2010Chk1\u2010Cdc25C and Weel pathways. Cancer science. 2013;104(8):1062\u20136. 10.1111/cas.12182", "ArticleIdList": ["10.1111/cas.12182", "PMC7657130", "23600770"]}, {"Citation": "Chuang C-Y, Liu H-C, Wu L-C, Chen C-Y, Chang JT, Hsu S-L. Gallic acid induces apoptosis of lung fibroblasts via a reactive oxygen species-dependent ataxia telangiectasia mutated-p53 activation pathway. Journal of agricultural and food chemistry. 2010;58(5):2943\u201351. 10.1021/jf9043265", "ArticleIdList": ["10.1021/jf9043265", "20151649"]}, {"Citation": "Bo S, Hui H, Li W, Hui L, Hong X, Lin D, et al. Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells. Food and Chemical Toxicology. 2014;68:61\u201370. 10.1016/j.fct.2014.03.007", "ArticleIdList": ["10.1016/j.fct.2014.03.007", "24650757"]}, {"Citation": "MacKenzie SH, Clark AC. Death by caspase dimerization Protein Dimerization and Oligomerization in Biology: Springer; 2012. p. 55\u201373.", "ArticleIdList": ["PMC3877935", "22949111"]}, {"Citation": "Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nature reviews Molecular cell biology. 2008;9(1):47\u201359.", "ArticleIdList": ["18097445"]}, {"Citation": "Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004;303(5659):844\u20138.", "ArticleIdList": ["14704432"]}, {"Citation": "Lai J-M, Chang JT, Wen C-L, Hsu S-L. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. European journal of pharmacology. 2009;623(1):1\u20139.", "ArticleIdList": ["19744477"]}, {"Citation": "D'arpa P, Liu LF. Topoisomerase-targeting antitumor drugs. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 1989;989(2):163\u201377.", "ArticleIdList": ["2557085"]}, {"Citation": "Wang JC. DNA topoisomerases. Annual review of biochemistry. 1996;65(1):635\u201392.", "ArticleIdList": ["8811192"]}, {"Citation": "Khadka DB, Cho W-J. 3-Arylisoquinolines as novel topoisomerase I inhibitors. Bioorganic & medicinal chemistry. 2011;19(2):724\u201334.", "ArticleIdList": ["21095131"]}, {"Citation": "K\u00fcmler I, Br\u00fcnner N, Stenvang J, Balslev E, Nielsen DL. A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer. Breast cancer research and treatment. 2013;138(2):347\u201358. 10.1007/s10549-013-2476-3", "ArticleIdList": ["10.1007/s10549-013-2476-3", "23512247"]}, {"Citation": "Du Z, Wang Y, Zhou Y, Wen F, Li Q. First-line irinotecan combined with 5-fluorouracil and leucovorin for high-grade metastatic gastrointestinal neuroendocrine carcinoma. Tumori. 2012;99(1):57\u201360.", "ArticleIdList": ["23549001"]}, {"Citation": "Barni S, Ghilardi M, Borgonovo K, Cabiddu M, Zaniboni A, Petrelli F. Cetuximab/Irinotecan-Chemotherapy in KRAS Wild-type Pretreated Metastatic Colorectal Cancer: A Pooled Analysis and Review of Literature. Reviews on recent clinical trials. 2013;8(2):101\u20139.", "ArticleIdList": ["23859115"]}, {"Citation": "Grossi F, Scolaro T, Tixi L, Loprevite M, Ardizzoni A. The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. Critical reviews in oncology/hematology. 2001;37(1):61\u20137.", "ArticleIdList": ["11164720"]}, {"Citation": "Le Treut J, Sault M, Lena H, Souquet P, Vergnenegre A, Le Caer H, et al. Multicentre phase II study of cisplatin\u2014etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Annals of oncology. 2013;24(6):1548\u201352. 10.1093/annonc/mdt009", "ArticleIdList": ["10.1093/annonc/mdt009", "23406729"]}, {"Citation": "Cao Y, Jin Z-X, Tong X-P, Yue S, Sakai T, Kawanami T, et al. Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis. Anticancer research. 2010;30(10):3911\u20137.", "ArticleIdList": ["21036702"]}, {"Citation": "K\u00f6cher S, Spies-Naumann A, Kriegs M, Dahm-Daphi J, Dornreiter I. ATM is required for the repair of Topotecan-induced replication-associated double-strand breaks. Radiotherapy and Oncology. 2013;108(3):409\u201314. 10.1016/j.radonc.2013.06.024", "ArticleIdList": ["10.1016/j.radonc.2013.06.024", "23928469"]}, {"Citation": "Wasierska-Gadek J, Maurer M. Promotion of apoptosis in cancer cells by selective purine-derived pharmacological CDK inhibitors: one outcome, many mechanisms. Current pharmaceutical design. 2011;17(3):256\u201371.", "ArticleIdList": ["21348827"]}, {"Citation": "Sun H, Hou H, Lu P, Zhang L, Zhao F, Ge C, et al. Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis. PloS one. 2012;7(5):e36808 10.1371/journal.pone.0036808", "ArticleIdList": ["10.1371/journal.pone.0036808", "PMC3356335", "22623962"]}, {"Citation": "Lin C-B, Lin C-C, Tsay GJ. 6-Gingerol inhibits growth of colon cancer cell LoVo via induction of G2/M arrest. Evidence-Based Complementary and Alternative Medicine. 2012;2012.", "ArticleIdList": ["PMC3375166", "22719783"]}, {"Citation": "Lee J-G, Kim J-H, Ahn J-H, Lee K-T, Baek N-I, Choi J-H. Jaceosidin, isolated from dietary mugwort (< i> Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation. Food and Chemical Toxicology. 2013;55:214\u201321. 10.1016/j.fct.2012.12.026", "ArticleIdList": ["10.1016/j.fct.2012.12.026", "23274058"]}, {"Citation": "Haug K, Kravik KL, De Angelis PM. Cellular response to irinotecan in colon cancer cell lines showing differential response to 5-fluorouracil. Anticancer research. 2008;28(2A):583\u201392.", "ArticleIdList": ["18506996"]}, {"Citation": "Mizutani H, Tada-Oikawa S, Hiraku Y, Oikawa S, Kojima M, Kawanishi S. Mechanism of apoptosis induced by a new topoisomerase inhibitor through the generation of hydrogen peroxide. Journal of Biological Chemistry. 2002;277(34):30684\u20139.", "ArticleIdList": ["12068015"]}, {"Citation": "Bouchier-Hayes L, Green D. Caspase-2: the orphan caspase. Cell Death & Differentiation. 2012;19(1):51\u20137.", "ArticleIdList": ["PMC3252831", "22075987"]}, {"Citation": "Fu Y-R, Yi Z-J, Yan Y-R, Qiu Z-Y. Hydroxycamptothecin-induced apoptosis in hepatoma SMMC-7721 cells and the role of mitochondrial pathway. Mitochondrion. 2006;6(4):211\u20137.", "ArticleIdList": ["16926123"]}, {"Citation": "Takeba Y, Sekine S, Kumai T, Matsumoto N, Nakaya S, Tsuzuki Y, et al. Irinotecan-induced apoptosis is inhibited by increased P-glycoprotein expression and decreased p53 in human hepatocellular carcinoma cells. Biological and Pharmaceutical Bulletin. 2007;30(8):1400\u20136.", "ArticleIdList": ["17666793"]}, {"Citation": "Korbakis D, Scorilas A. Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12. Tumor Biology. 2009;30(2):100\u20137. 10.1159/000218160", "ArticleIdList": ["10.1159/000218160", "19440006"]}, {"Citation": "Lien J-C, Huang C-C, Lu T-J, Tseng C-H, Sung P-J, Lee H-Z, et al. Naphthoquinone Derivative PPE8 Induces Endoplasmic Reticulum Stress in p53 Null H1299 Cells. Oxidative Medicine and Cellular Longevity. 2015;2015.", "ArticleIdList": ["PMC4313521", "25685256"]}, {"Citation": "Thomas A, Perry T, Berhane S, Oldreive C, Zlatanou A, Williams L, et al. The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53. Oncogene. 2014.", "ArticleIdList": ["25132271"]}, {"Citation": "Provinciali M, Cardelli M, Marchegiani F, Pierpaoli E. Impact of cellular senescence in aging and cancer. Current pharmaceutical design. 2013;19(9):1699\u2013709.", "ArticleIdList": ["23061727"]}, {"Citation": "Chen MC, Pan SL, Shi Q, Xiao Z, Lee KH, Li TK, et al. QS\u2010ZYX\u20101\u201061 induces apoptosis through topoisomerase II in human non\u2010small\u2010cell lung cancer A549 cells. Cancer science. 2012;103(1):80\u20137. 10.1111/j.1349-7006.2011.02103.x", "ArticleIdList": ["10.1111/j.1349-7006.2011.02103.x", "21920000"]}, {"Citation": "Wu S-Y, Pan S-L, Xiao Z-Y, Hsu J-L, Chen M-C, Lee K-H, et al. NPRL-Z-1, as a New Topoisomerase II Poison, Induces Cell Apoptosis and ROS Generation in Human Renal Carcinoma Cells. PloS one. 2014;9(11):e112220 10.1371/journal.pone.0112220", "ArticleIdList": ["10.1371/journal.pone.0112220", "PMC4221609", "25372714"]}, {"Citation": "White Y, Hamada T, Yoshimitsu M, Nakashima M, Hachiman M, Kozako T, et al. Novel cytotoxic isolated from Jamaican Hyptis verticillata jacq induces apoptosis and overcomes multidrug resistance. Anticancer research. 2011;31(12):4251\u20137.", "ArticleIdList": ["22199288"]}, {"Citation": "Wang T, Chen F, Chen Z, Wu Y-F, Xu X-L, Zheng S, et al. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World Journal of Gastroenterology. 2004;10(15):2205\u20138.", "ArticleIdList": ["PMC4724979", "15259066"]}, {"Citation": "Wu J, Hu C-p, Gu Q-h, Li Y-p, Song M. Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase. Acta Pharmacologica Sinica. 2010;31(1):93\u2013101. 10.1038/aps.2009.183", "ArticleIdList": ["10.1038/aps.2009.183", "PMC4002697", "20048748"]}, {"Citation": "He H-Y, Zhao J-N, Jia R, Zhao Y-L, Yang S-Y, Yu L-T, et al. Novel Pyrazolo [3, 4-d] pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation. Molecules. 2011;16(12):10685\u201394. 10.3390/molecules161210685", "ArticleIdList": ["10.3390/molecules161210685", "PMC6264756", "22186955"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "1", "Day": "9"}, {"Year": "2015", "Month": "6", "Day": "9"}, {"Year": "2015", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "7", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["26147394", "PMC4492957", "10.1371/journal.pone.0132052", "PONE-D-15-00568"]}}], "PubmedBookArticle": []}